VRTX

VERTEX PHARMACEUTICALS INC / MA · Wikipedia · Yahoo Finance chart ↗

Price

Last close: $514.63Last update Sep 15, 2026
12-month high: $560.25
12-month low: $374.17

Reported holders

Reported purchases with no subsequent reported sale.

Name	Purchased	Price that day	ROI
Alan Armstrong	Mar 27, 2026	$433.07	+18.83%
Julia Letlow Rank #9	Oct 23, 2024	$470.05	+9.48%
William R. Keating Rank #126	Mar 29, 2022	$257.98	+99.48%

Prices are the market close on the purchase date; exact purchase prices are not disclosed. ROI is the percentage gain or loss from that price to the last close.

All trades

Public-equity transactions, newest transaction dates first
Ticker	Politician Name	Transaction Type	Trade Date	Found Date
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], David J. Taylor, sale, Aug 26, 2026	David J. Taylor Rank #50	Sale	Aug 26, 2026	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock, Alan Armstrong, purchase, Mar 27, 2026	Alan Armstrong	Purchase	Mar 27, 2026	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], David J. Taylor, sale, Jan 29, 2026	David J. Taylor Rank #50	Sale	Jan 29, 2026	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], David J. Taylor, purchase, Aug 7, 2025	David J. Taylor Rank #50	Purchase	Aug 7, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Lisa McClain, sale, Jun 11, 2025	Lisa McClain Rank #2	Sale	Jun 11, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Lisa McClain, sale, Jun 10, 2025	Lisa McClain Rank #2	Sale	Jun 10, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Jefferson Shreve, sale, May 12, 2025	Jefferson Shreve Rank #120	Sale	May 12, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Byron Donalds, sale, Mar 20, 2025	Byron Donalds Rank #53	Sale	Mar 20, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Jefferson Shreve, purchase, Mar 13, 2025	Jefferson Shreve Rank #120	Purchase	Mar 13, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Jefferson Shreve, purchase, Feb 24, 2025	Jefferson Shreve Rank #120	Purchase	Feb 24, 2025	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Lisa McClain, purchase, Dec 11, 2024	Lisa McClain Rank #2	Purchase	Dec 11, 2024	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST], Julia Letlow, purchase, Oct 23, 2024	Julia Letlow Rank #9	Purchase	Oct 23, 2024	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock, Thomas H Tuberville, sale, May 3, 2024	Thomas H Tuberville Rank #107	Sale	May 3, 2024	Sep 11, 2026
VRTX — Vertex Pharmaceuticals Incorporated (VRTX) [ST], Greg Stanton, sale, Oct 24, 2023	Greg Stanton Rank #72	Sale	Oct 24, 2023	Sep 12, 2026
VRTX — Vertex Pharmaceuticals Incorporated (VRTX) [ST], Greg Stanton, purchase, Sep 26, 2023	Greg Stanton Rank #72	Purchase	Sep 26, 2023	Sep 12, 2026
VRTX — Vertex Pharmaceuticals Incorporated - Common Stock, Thomas H Tuberville, purchase, Oct 6, 2022	Thomas H Tuberville Rank #107	Purchase	Oct 6, 2022	Sep 12, 2026
VRTX — Vertex Pharmaceuticals Incorporated (VRTX) [ST], William R. Keating, purchase, Mar 29, 2022	William R. Keating Rank #126	Purchase	Mar 29, 2022	Sep 12, 2026